preemption News
Most Popular preemption Story
Did Merck settle too soon?
Yesterday, we reported that two appeals courts--in Texas and New Jersey--overturned multimillion-dollar verdicts against Merck in Vioxx cases. The Jersey court's reasoning: A state product liability Read more...
Latest Headlines
- August 30, 2011
- June 23, 2011
- June 15, 2011
- June 2, 2011
- May 27, 2009
- April 30, 2009
- March 11, 2009
- March 5, 2009
- March 4, 2009
- November 5, 2008
- November 4, 2008
- November 3, 2008
- October 30, 2008
- October 14, 2008
- September 18, 2008
- August 15, 2008
- August 7, 2008
- July 21, 2008
- June 27, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
